Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL - Narrative (Details)

v3.21.2
SHARE CAPITAL - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended
Apr. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Dec. 31, 2020
Business Acquisition, Equity Interests Issued or Issuable [Line Items]        
Common stock, shares authorized     900,000,000 900,000,000
Common stock, par value (in dollars per share)     $ 0.001 $ 0.001
Common stock, shares issued     58,692,701 56,378,939
Common stock, shares outstanding     58,692,701 56,378,939
Shares issued   780,162    
Share price   $ 0.80    
Conversion price (in dollars per share)     $ 1.40  
Shares issued on conversion of debt     52,633  
Sentry Neuromonitoring, LLC        
Business Acquisition, Equity Interests Issued or Issuable [Line Items]        
Value of common stock issuable $ 1,625,000      
Common stock issuable 1,186,129      
Held in escrow, Value $ 650,000      
Held in escrow, Shares 474,452      
Common stock lock up period 12 months